Medtech Talk

Episode 171: Viz.ai CEO Chris Mansi on Artificial Intelligence and Increasing Patient Access to Life-Saving Treatments

October 18, 2022 Healthegy Season 2 Episode 171
Episode 171: Viz.ai CEO Chris Mansi on Artificial Intelligence and Increasing Patient Access to Life-Saving Treatments
Medtech Talk
More Info
Medtech Talk
Episode 171: Viz.ai CEO Chris Mansi on Artificial Intelligence and Increasing Patient Access to Life-Saving Treatments
Oct 18, 2022 Season 2 Episode 171
Healthegy

As a trained neurosurgeon, Dr. Chris Mansi is familiar with the challenges patients face in accessing lifesaving treatments. After earning an MBA from Stanford and enrolling in their Biodesign Medical Innovation track, he learned to develop multifaceted and technology-based solutions to improve healthcare workflows. 
 
In this episode, host Geoff Pardo speaks with Mansi about Viz.ai, a revolutionary application that increases patient access to life-saving treatments in over 1,200 hospitals. Every minute an ischemic stroke patient waits for treatment equates to approximately 2 million neurons lost and a week of disability. Viz.ai abbreviates the sometimes five-hour-long process of securing a specialist to merely minutes, changing the course of patients’ lives. Mansi also discusses how to address naivety in entrepreneurship, the value of an interdisciplinary mindset in improving patient outcomes, and the importance of creating a value-based company with mission-driven employees. 

Links from this episode:  
Viz.ai 

Show Notes

As a trained neurosurgeon, Dr. Chris Mansi is familiar with the challenges patients face in accessing lifesaving treatments. After earning an MBA from Stanford and enrolling in their Biodesign Medical Innovation track, he learned to develop multifaceted and technology-based solutions to improve healthcare workflows. 
 
In this episode, host Geoff Pardo speaks with Mansi about Viz.ai, a revolutionary application that increases patient access to life-saving treatments in over 1,200 hospitals. Every minute an ischemic stroke patient waits for treatment equates to approximately 2 million neurons lost and a week of disability. Viz.ai abbreviates the sometimes five-hour-long process of securing a specialist to merely minutes, changing the course of patients’ lives. Mansi also discusses how to address naivety in entrepreneurship, the value of an interdisciplinary mindset in improving patient outcomes, and the importance of creating a value-based company with mission-driven employees. 

Links from this episode:  
Viz.ai